N

Nektar Therapeutics
D

NKTR

73.890
USD
0.72
(0.98%)
مغلق
حجم التداول
37,357
الربح لكل سهم
-10
العائد الربحي
-
P/E
-8
حجم السوق
2,067,406,733
أصول ذات صلة المقالات

العنوان: Nektar Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.